DZ2742A1 - Nouveaux procédés pour la préparation de (r)-beta-(2,3-diméthoxy phényl)-1-Ä2-(4-fluorophényl)éthylÜ-4-pipéridineméthanol. - Google Patents

Nouveaux procédés pour la préparation de (r)-beta-(2,3-diméthoxy phényl)-1-Ä2-(4-fluorophényl)éthylÜ-4-pipéridineméthanol.

Info

Publication number: DZ2742A1
Authority: DZ; Algeria
Prior art keywords: ethylü; piperidinemethanol; fluorophenyl; beta; preparation
Prior art date: 1998-03-13

Application number

DZ990043A

Other languages

English (en)

Inventor

Alan G Bina

Edward D Daugs

Jonathan C Evans

Hans W Flemming

Gerard Guillamot

Robert A Hawthorne

Thomas H E Hilpert

James E Hitt

Chi-Hsin R King

Johannes N Koek

Frederick M Laskovics

John R Lefler

Alexy L Margolin

Sharon K Minish

Thomas T Ortyl

Lian G Rajewski

Marvin J Sack

Paul F Skultety

Sandra K Stolz-Dunn

Alonzo L Tigner

Ian A Tolinson

Original Assignee

Hoechst Marion Roussel Inc

Hoechst Marion Roussel De Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-13

Filing date

1999-03-10

Publication date

2003-09-08

1999-03-10 Application filed by Hoechst Marion Roussel Inc, Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel Inc

2003-09-08 Application granted granted Critical

2003-09-08 Publication of DZ2742A1 publication Critical patent/DZ2742A1/fr

Links

125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 title 1
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Medicinal Preparation (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DZ990043A 1998-03-13 1999-03-10 Nouveaux procédés pour la préparation de (r)-beta-(2,3-diméthoxy phényl)-1-Ä2-(4-fluorophényl)éthylÜ-4-pipéridineméthanol. DZ2742A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4225198A	1998-03-13	1998-03-13
US25071899A	1999-02-16	1999-02-16

Publications (1)

Publication Number	Publication Date
DZ2742A1 true DZ2742A1 (fr)	2003-09-08

Family

ID=26719032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990043A DZ2742A1 (fr)	1998-03-13	1999-03-10	Nouveaux procédés pour la préparation de (r)-beta-(2,3-diméthoxy phényl)-1-Ä2-(4-fluorophényl)éthylÜ-4-pipéridineméthanol.

Country Status (25)

Country	Link
EP (3)	EP1736469A3 (fr)
JP (2)	JP4511723B2 (fr)
KR (7)	KR100586328B1 (fr)
CN (1)	CN100436415C (fr)
AR (1)	AR015540A1 (fr)
AT (1)	ATE373639T1 (fr)
AU (1)	AU755436B2 (fr)
BR (1)	BR9909260A (fr)
CA (1)	CA2322501C (fr)
CY (1)	CY1107104T1 (fr)
DE (1)	DE69937162T2 (fr)
DK (1)	DK1192134T3 (fr)
DZ (1)	DZ2742A1 (fr)
EG (1)	EG24052A (fr)
ES (1)	ES2294838T3 (fr)
HK (1)	HK1042484B (fr)
HU (1)	HUP0400889A3 (fr)
IL (3)	IL138307A0 (fr)
MA (1)	MA25515A1 (fr)
NO (1)	NO317981B1 (fr)
NZ (1)	NZ506807A (fr)
PT (1)	PT1192134E (fr)
TN (1)	TNSN99035A1 (fr)
TW (1)	TWI249526B (fr)
WO (1)	WO1999046245A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6713627B2 (en) *	1998-03-13	2004-03-30	Aventis Pharmaceuticals Inc.	Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
DE19934432A1 (de)	1999-07-22	2001-02-01	Merck Patent Gmbh	Indolderivate
WO2002072069A1 (fr) *	2001-03-12	2002-09-19	Novo Nordisk A/S	Nouveaux comprimes et gelules et procede de preparation correspondant
DE102004010132A1 (de)	2004-02-27	2005-09-15	Merck Patent Gmbh	Piperidinderivate
CA2672134C (fr) *	2006-12-07	2015-02-10	Daiichi Sankyo Company, Limited	Preparation medicale sous forme solide contenant un mannitol ou un lactose
US8964338B2 (en)	2012-01-11	2015-02-24	Emerson Climate Technologies, Inc.	System and method for compressor motor protection
EP2971989A4 (fr)	2013-03-15	2016-11-30	Emerson Electric Co	Diagnostic et système de télésurveillance de chauffage, de ventilation et de climatisation
CN112358398A (zh) *	2020-11-19	2021-02-12	山东新华制药股份有限公司	D-(+)-二对甲苯甲酰酒石酸的回收制备方法
CN116082705B (zh) *	2022-12-05	2023-09-12	苏州易昇光学材料股份有限公司	一种抗黄变自修复凝胶

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4260623A (en) *	1979-11-26	1981-04-07	Warner-Lambert Company	Hexahydro-1-arylspiro(3H-oxazolo(3,4-A)pyridine-3,4'-piperidene) antidepressants, pharmaceutical compositions thereof and method of use thereof
CA1280421C (fr) *	1985-07-02	1991-02-19	Albert A. Carr	Derives piperidinyl disubstitutes en 1,4
US5169096A (en) *	1985-07-02	1992-12-08	Merrell Dow Pharmaceuticals Inc.	N-aralkyl-piperidine-methanol derivatives
WO1991018602A1 (fr) *	1990-06-01	1991-12-12	Merrell Dow Pharmaceuticals Inc.	(+)-α-(2,3-DIMETHOXYPHENYLE)-1-[2-(4-FLUOROPHENYLE)ETHYLE]-4-PIPERIDINEMETHANOL
ATE144899T1 (de) *	1990-06-07	1996-11-15	Merrell Pharma Inc	Derivate des 1-piperidinyl- alkanoylarylsulfonamids
US5477029A (en) *	1994-01-28	1995-12-19	Skutt Ceramic Products, Inc.	Kiln with hinged control panel
US5618824A (en) *	1994-03-09	1997-04-08	Merrell Pharmaceuticals Inc.	Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
EP0796619A1 (fr) *	1996-03-21	1997-09-24	Merrell Pharmaceuticals Inc.	Utilisation de (+)-alpha-(2,3-diméthoxyphényle)-1-(2-(4-fluorophényle)éthyle)-4-pipéridineméthanol pour le traitement des troubles dépressifs et bipolaires

1999
- 1999-03-09 TW TW088103619A patent/TWI249526B/zh not_active IP Right Cessation
- 1999-03-10 EG EG23399A patent/EG24052A/xx active
- 1999-03-10 DZ DZ990043A patent/DZ2742A1/fr active
- 1999-03-10 MA MA25491A patent/MA25515A1/fr unknown
- 1999-03-11 HU HU0400889A patent/HUP0400889A3/hu unknown
- 1999-03-11 KR KR1020057024570A patent/KR100586328B1/ko not_active Expired - Fee Related
- 1999-03-11 AU AU29988/99A patent/AU755436B2/en not_active Ceased
- 1999-03-11 AR ARP990101039A patent/AR015540A1/es unknown
- 1999-03-11 EP EP06016487A patent/EP1736469A3/fr not_active Withdrawn
- 1999-03-11 EP EP06016486A patent/EP1734037A3/fr not_active Ceased
- 1999-03-11 EP EP99911318A patent/EP1192134B1/fr not_active Expired - Lifetime
- 1999-03-11 IL IL13830799A patent/IL138307A0/xx active IP Right Grant
- 1999-03-11 PT PT99911318T patent/PT1192134E/pt unknown
- 1999-03-11 KR KR1020057024567A patent/KR100591643B1/ko not_active Expired - Fee Related
- 1999-03-11 DE DE69937162T patent/DE69937162T2/de not_active Expired - Lifetime
- 1999-03-11 KR KR1020057024569A patent/KR100586327B1/ko not_active Expired - Fee Related
- 1999-03-11 WO PCT/US1999/005332 patent/WO1999046245A2/fr not_active Ceased
- 1999-03-11 ES ES99911318T patent/ES2294838T3/es not_active Expired - Lifetime
- 1999-03-11 BR BR9909260-3A patent/BR9909260A/pt not_active Application Discontinuation
- 1999-03-11 AT AT99911318T patent/ATE373639T1/de not_active IP Right Cessation
- 1999-03-11 KR KR1020057024568A patent/KR100591640B1/ko not_active Expired - Fee Related
- 1999-03-11 CA CA002322501A patent/CA2322501C/fr not_active Expired - Fee Related
- 1999-03-11 CN CNB998060224A patent/CN100436415C/zh not_active Expired - Fee Related
- 1999-03-11 DK DK99911318T patent/DK1192134T3/da active
- 1999-03-11 KR KR1020057024572A patent/KR100591997B1/ko not_active Expired - Fee Related
- 1999-03-11 HK HK02103493.4A patent/HK1042484B/en not_active IP Right Cessation
- 1999-03-11 KR KR1020007010103A patent/KR100591642B1/ko not_active Expired - Fee Related
- 1999-03-11 JP JP2000535626A patent/JP4511723B2/ja not_active Expired - Fee Related
- 1999-03-11 TN TNTNSN99035A patent/TNSN99035A1/fr unknown
- 1999-03-11 NZ NZ506807A patent/NZ506807A/xx unknown
- 1999-03-11 KR KR1020057024573A patent/KR100591641B1/ko not_active Expired - Fee Related
2000
- 2000-09-06 IL IL138307A patent/IL138307A/en not_active IP Right Cessation
- 2000-09-12 NO NO20004545A patent/NO317981B1/no not_active IP Right Cessation
2006
- 2006-05-29 IL IL175983A patent/IL175983A0/en unknown
2007
- 2007-12-19 CY CY20071101617T patent/CY1107104T1/el unknown
2009
- 2009-12-28 JP JP2009296809A patent/JP2010143925A/ja not_active Abandoned

Also Published As

Publication number	Publication date
AR015540A1 (es)	2001-05-02
TNSN99035A1 (fr)	2005-11-10
NO317981B1 (no)	2005-01-17
WO1999046245A2 (fr)	1999-09-16
JP2002506059A (ja)	2002-02-26
NO20004545L (no)	2000-11-13
KR100586328B1 (ko)	2006-06-08
NZ506807A (en)	2003-03-28
CA2322501C (fr)	2006-05-09
DE69937162D1 (de)	2007-10-31
MA25515A1 (fr)	2002-10-01
EP1734037A3 (fr)	2010-06-16
KR20060002037A (ko)	2006-01-06
PT1192134E (pt)	2007-11-13
ES2294838T3 (es)	2008-04-01
CA2322501A1 (fr)	1999-09-16
HUP0400889A2 (hu)	2004-08-30
HK1042484A1 (en)	2002-08-16
ATE373639T1 (de)	2007-10-15
IL138307A0 (en)	2001-10-31
KR20060002036A (ko)	2006-01-06
BR9909260A (pt)	2000-11-21
IL138307A (en)	2006-09-05
KR20060002035A (ko)	2006-01-06
KR100591641B1 (ko)	2006-06-20
AU755436B2 (en)	2002-12-12
KR100591997B1 (ko)	2006-06-26
EP1192134A2 (fr)	2002-04-03
KR20060002034A (ko)	2006-01-06
EP1192134B1 (fr)	2007-09-19
KR20060002039A (ko)	2006-01-06
KR100591640B1 (ko)	2006-06-20
CN100436415C (zh)	2008-11-26
EP1734037A2 (fr)	2006-12-20
HUP0400889A3 (en)	2010-08-30
IL175983A0 (en)	2006-10-05
JP2010143925A (ja)	2010-07-01
EP1736469A3 (fr)	2010-06-09
KR100591642B1 (ko)	2006-06-20
TWI249526B (en)	2006-02-21
DK1192134T3 (da)	2007-11-26
EP1736469A2 (fr)	2006-12-27
KR100586327B1 (ko)	2006-06-08
EG24052A (en)	2008-04-13
DE69937162T2 (de)	2008-06-12
NO20004545D0 (no)	2000-09-12
HK1042484B (en)	2008-05-02
WO1999046245A3 (fr)	1999-10-21
CN1300280A (zh)	2001-06-20
KR100591643B1 (ko)	2006-06-20
KR20060002038A (ko)	2006-01-06
CY1107104T1 (el)	2012-01-25
AU2998899A (en)	1999-09-27
KR20010041819A (ko)	2001-05-25
JP4511723B2 (ja)	2010-07-28

Publication	Publication Date	Title
DZ2247A1 (fr)	2002-12-18	Procédé pour la préparation du sildénafil.
DZ3079A1 (fr)	2004-10-24	Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
NO20011214L (no)	2001-05-10	Fremgangsmåte for fremstilling av aromatiske aldehyder
NO20011936L (no)	2001-06-01	Fremgangsmate for fremstilling av citalopram
EP1093448A4 (fr)	2004-12-15	Procede de preparation de mousses ceramiques
IT1295645B1 (it)	1999-05-24	Apparecchio per l'elettroemanazione di principi attivi.
DZ2912A1 (fr)	2004-03-01	Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.
DZ2641A1 (fr)	2003-03-15	Nouveaux procédés pour la préparation d'oméprazole.
DE69908533D1 (de)	2003-07-10	Verfahren zur Herstellung von 3,3,5-Trimethylcyclohexylidenebisphenolen
ZA200004914B (en)	2001-08-10	Process for the preparation of bisphosphines.
DK0952137T3 (da)	2004-11-08	Fremgangsmåde til fremstilling af 2,3,5-trimethylhydroquinondiestere
TR199800403A3 (tr)	1998-09-21	a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
GB2343892B (en)	2004-06-09	Process for the preparation of d,l-menthol
EG24052A (en)	2008-04-13	Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
NO985535D0 (no)	1998-11-27	FremgangsmÕte for fremstilling av 1,3-alkandioler
TR199700174A2 (tr)	1997-09-21	Asimetrik 4,6-bis(ariloksi)pirimidin bilesiklerinin hazirlanmasi icin proses.
DE69913635D1 (de)	2004-01-29	Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE60004931D1 (de)	2003-10-09	Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
TR199901165A3 (tr)	1999-12-21	Piretroid bilesimi ve salgin hastaliklari için bunu içeren bilesikler.
ZA200102818B (en)	2001-11-15	Process for the preparation of 4,4'-dihalogen-O-hydroxydiphenyl compounds.
FI964829A0 (fi)	1996-12-03	Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi
NO20005158D0 (no)	2000-10-13	FremgangsmÕte for fremstilling av R-(+)-6-karboksamido-3-N- metylamino-1,2,3,4-tetrahydrokarbazol
TR199900757A3 (tr)	1999-11-22	Fenoksifenilsülfonil halidlerin hazirlanmasi için islem.
DE59900401D1 (de)	2001-12-13	Verfahren zur Herstellung von 1,3-Dimethyl-imidazolium-4-carboxylat
FR2778917B1 (fr)	2000-06-30	Nouveaux derives d'histidine, procede de preparation et utilisations